Data is not available at this time.
Sunresin New Materials operates as a specialized chemical company focused on the research, development, and manufacturing of adsorption and separation materials and systems. The company's core revenue model centers on producing and selling a diverse portfolio of ion exchange resins, chromatographic media, enzyme carriers, and customized separation solutions. These high-value functional materials serve critical purification and separation processes across multiple industrial sectors, creating a diversified revenue base. Sunresin has established a strong market position in China's specialty chemicals landscape by developing proprietary technologies for complex separation challenges. The company serves demanding end-markets including biopharmaceuticals, food and beverage processing, hydrometallurgy, and industrial water treatment, where product performance and reliability are paramount. Its integrated approach—combining material science with system engineering—allows Sunresin to deliver complete solutions rather than just components, creating higher barriers to entry and stronger customer relationships. The company's focus on research-intensive applications positions it favorably in growth segments like life sciences and sustainable technologies, where separation efficiency directly impacts operational outcomes and regulatory compliance.
Sunresin demonstrated robust financial performance with revenue of CNY 2.55 billion and net income of CNY 787 million, translating to a healthy net margin of approximately 31%. The company generated strong operating cash flow of CNY 732 million, significantly exceeding capital expenditures of CNY 179 million. This indicates efficient capital allocation and the ability to fund growth internally while maintaining profitability. The substantial cash generation relative to investments suggests the business model requires moderate reinvestment to sustain operations.
The company exhibits strong earnings power with diluted EPS of CNY 1.55, reflecting effective utilization of its equity base. Operating cash flow coverage of capital expenditures at over 4 times demonstrates exceptional capital efficiency in converting investments into cash returns. The business model appears to generate substantial returns on incremental capital, supported by the significant cash balance accumulation relative to the scale of ongoing investments required for maintenance and growth.
Sunresin maintains a conservative financial structure with cash and equivalents of CNY 2.26 billion significantly exceeding total debt of CNY 469 million, resulting in a net cash position. This strong liquidity profile provides substantial financial flexibility for strategic initiatives and weathers potential market volatility. The minimal leverage indicates a low-risk balance sheet that can support both organic growth and potential strategic acquisitions without compromising financial stability.
The company has implemented a shareholder-friendly capital return policy, distributing a dividend of CNY 0.719 per share. This dividend payout represents a sustainable distribution given the strong earnings and cash flow generation. The combination of growth investments and dividend payments suggests a balanced approach to capital allocation that rewards shareholders while funding future expansion opportunities in its core specialty materials markets.
With a market capitalization of approximately CNY 27.2 billion, the company trades at a P/E ratio of around 34.5 times trailing earnings, reflecting market expectations for continued growth in its specialty chemicals niche. The beta of 0.41 indicates lower volatility compared to the broader market, suggesting investors perceive the business as having defensive characteristics despite its growth-oriented valuation multiple.
Sunresin's competitive advantages stem from its deep technical expertise in adsorption science and its integrated product-system approach. The company's diverse application base across multiple industrial sectors provides natural hedging against cyclicality in any single market. Future growth will likely depend on continued innovation in separation technologies and expansion into adjacent high-value applications, particularly in biopharmaceuticals and environmental solutions where regulatory trends favor advanced purification systems.
Company Financial StatementsShenzhen Stock Exchange Filings
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |